# Novo Nordisk plans CNY400M investment company in China

Danish biopharmaceutical firm Novo Nordisk announced plans to invest CNY400 million to set up an investment company in China to integrate its business resources.

- Type: Investment
- Announced: 2022-11-07
- Where: China
- Value: $55.7M (400.0M CNY)
- Status: announced
- Products: investment company
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Novo Nordisk](https://endata.com/companies/17868.md)

## Sources

- [yicaiglobal.com](https://www.yicaiglobal.com/news/international-medical-firms-strike-deals-with-chinese-partners-at-5th-ciie), 2022-11-07: "Novo Nordisk announced during the expo that the Danish biopharmaceutical firm plans to invest CNY400 million (USD55.7 million) to set up an investment company to integrate its business r"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.